Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Protein Networks02:26

Protein Networks

2.8K
2.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.4K
Network Covalent Solids02:18

Network Covalent Solids

16.1K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.1K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

2.9K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.9K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

3.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
Same author

Physician-Reported Diagnostic Uncertainty Among Children Discharged From the Pediatric Emergency Department With Acute Respiratory Illness.

Pediatric emergency care·2026
Same author

Nirmatrelvir/ritonavir use reduces risk for long COVID in patients with immunodeficiency.

Journal of human immunity·2026
Same author

Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
Same author

Differences in immunoglobulin utilization when treating patients with primary immune disease in the United States.

The journal of allergy and clinical immunology. Global·2026
Same author

Sociodemographic drivers of care disparity among patients with inborn errors of immunity.

Current opinion in pediatrics·2025
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches
09:04

Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches

Published on: October 27, 2013

15.0K

A Bayesian Network Approach to Disease Subtype Discovery.

Mei-Sing Ong1,2

  • 1Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, USA. mei-sing_ong@hms.harvard.edu.

Methods in Molecular Biology (Clifton, N.J.)
|March 9, 2019
PubMed
Summary
This summary is machine-generated.

This study used Bayesian network analysis to identify distinct subtypes of pediatric pulmonary hypertension. The findings reveal rare disease subtypes, improving classification and paving the way for targeted therapies.

Keywords:
Bayesian network analysisDisease subtypePulmonary hypertension

More Related Videos

Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.4K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.6K

Related Experiment Videos

Last Updated: Jan 28, 2026

Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches
09:04

Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches

Published on: October 27, 2013

15.0K
Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.4K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.6K

Area of Science:

  • Genomics
  • Computational Biology
  • Pediatric Medicine

Background:

  • Human diseases are traditionally classified by affected organs, but genomic and proteomic data reveal significant heterogeneity within disease categories.
  • Many diseases comprise distinct molecular and clinical subtypes that share an anatomical location, complicating traditional classification and treatment.
  • Pediatric pulmonary hypertension (PPH) serves as a model to explore disease heterogeneity using advanced computational methods.

Purpose of the Study:

  • To apply Bayesian network analysis to identify and validate disease subtypes in pediatric pulmonary hypertension based on comorbidity patterns.
  • To uncover rare or previously unrecognized subtypes of PPH that are not apparent through clinical observation alone.
  • To provide a foundation for refining disease classifications and developing more targeted therapeutic strategies for PPH.

Main Methods:

  • Bayesian network analysis was employed to model complex relationships between comorbidities.
  • High-throughput genomic and proteomic data were implicitly leveraged to inform the comorbidity patterns studied.
  • The analysis focused on identifying distinct clusters or subtypes within the pediatric pulmonary hypertension cohort.

Main Results:

  • The Bayesian network analysis successfully relearned previously established subtypes of pediatric pulmonary hypertension, validating the analytical approach.
  • Novel and rare subtypes of pediatric pulmonary hypertension were identified, which are not easily discernible through conventional clinical assessments.
  • The identified subtypes offer a more granular understanding of PPH heterogeneity.

Conclusions:

  • Bayesian network analysis is a powerful tool for dissecting disease heterogeneity and identifying novel subtypes, as demonstrated in pediatric pulmonary hypertension.
  • The discovery of rare subtypes necessitates further investigation to understand their unique characteristics and clinical implications.
  • Linking these molecularly defined subtypes to therapeutic responses and outcomes is crucial for advancing personalized medicine in pediatric pulmonary hypertension.